Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Exenatide

ECHO

AstraZeneca · Phase 3 · Completed · Enrollment 42

NCT02664441

Y axis: Change in body weight from baseline, %

500481216202436Exenatide once weekly extended-release, week 36, 1.7%Exenatide once weekly extended-releaseMatching placebo, week 36, 3.5%Matching placebo

X axis: Weeks since randomization

Cited trial source. Only weeks the source states.

  • Exenatide once weekly extended-release: week 36 1.7%
  • Matching placebo: week 36 3.5%

One reported week is a point at that week. It is not a line from 0%. A solid line connects two or more reported weeks.